SOLACI Session

The Role of the Interventional Cardiologist in the Treatment of Venous Disease

solaci
solaci
431
0

sesion_solaci_acc2013_oscar_mendiz

Oscar Mendiz
2013-03-09

Previous article
PARTNER cohort A at three years, the benefit continues
Next article
Endovascular theraphy for acute and critical limb ischemia
solaci
solaci

More articles by this author

An interventional cardiologist`s perspective on endovascular therapy for AAA

solaci - 0
Guering Eid-Lidt2013-03-09

CREST, ACT 1 and Other Trials

solaci - 0
William A. Gray2013-03-09

Endovascular theraphy for acute and critical limb ischemia

solaci - 0
Felix Damas De Los Santos2013-03-10

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Dr. Omar Tupayachi - 0
Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Dr. Juan Manuel Pérez - 0
Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Dr. Juan Manuel Pérez - 0
Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...